Back to Search Start Over

The genomic landscape across 474 surgically accessible epileptogenic human brain lesions

Authors :
Lopez-Rivera, Javier A.
Leu, Costin
Macnee, Marie
Khoury, Jean
Hoffmann, Lucas
Coras, Roland
Kobow, Katja
Bhattarai, Nisha
Perez-Palma, Eduardo
Hamer, Hajo
Brandner, Sebastian
Roessler, Karl
Bien, Christian G.
Kalbhenn, Thilo
Pieper, Tom
Hartlieb, Till
Butler, Elizabeth
Genovese, Giulio
Becker, Kerstin
Altmueller, Janine
Niestroj, Lisa-Marie
Ferguson, Lisa
Busch, Robyn M.
Nuernberg, Peter
Najm, Imad
Bluemcke, Ingmar
Lal, Dennis
Lopez-Rivera, Javier A.
Leu, Costin
Macnee, Marie
Khoury, Jean
Hoffmann, Lucas
Coras, Roland
Kobow, Katja
Bhattarai, Nisha
Perez-Palma, Eduardo
Hamer, Hajo
Brandner, Sebastian
Roessler, Karl
Bien, Christian G.
Kalbhenn, Thilo
Pieper, Tom
Hartlieb, Till
Butler, Elizabeth
Genovese, Giulio
Becker, Kerstin
Altmueller, Janine
Niestroj, Lisa-Marie
Ferguson, Lisa
Busch, Robyn M.
Nuernberg, Peter
Najm, Imad
Bluemcke, Ingmar
Lal, Dennis

Abstract

Lopez-Rivera et al. discover differences in genetic architecture across major epileptic brain lesion types. They describe novel somatic chromosomal alterations, identify novel genes and genotype-phenotype associations, and provide support for the role of genetics in the histopathological diagnosis of epileptic lesions. Understanding the exact molecular mechanisms involved in the aetiology of epileptogenic pathologies with or without tumour activity is essential for improving treatment of drug-resistant focal epilepsy. Here, we characterize the landscape of somatic genetic variants in resected brain specimens from 474 individuals with drug-resistant focal epilepsy using deep whole-exome sequencing (>350x) and whole-genome genotyping. Across the exome, we observe a greater number of somatic single-nucleotide variants in low-grade epilepsy-associated tumours (7.92 +/- 5.65 single-nucleotide variants) than in brain tissue from malformations of cortical development (6.11 +/- 4 single-nucleotide variants) or hippocampal sclerosis (5.1 +/- 3.04 single-nucleotide variants). Tumour tissues also had the largest number of likely pathogenic variant carrying cells. low-grade epilepsy-associated tumours had the highest proportion of samples with one or more somatic copy-number variants (24.7%), followed by malformations of cortical development (5.4%) and hippocampal sclerosis (4.1%). Recurring somatic whole chromosome duplications affecting Chromosome 7 (16.8%), chromosome 5 (10.9%), and chromosome 20 (9.9%) were observed among low-grade epilepsy-associated tumours. For germline variant-associated malformations of cortical development genes such as TSC2, DEPDC5 and PTEN, germline single-nucleotide variants were frequently identified within large loss of heterozygosity regions, supporting the recently proposed 'second hit' disease mechanism in these genes. We detect somatic variants in 12 established lesional epilepsy genes and demonstrate exome-wide statistical support for three

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1383745317
Document Type :
Electronic Resource